[Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo
V
V
Unidad de Hepatología, Institut de Malalties Digestives, Hospital Clínic Universitari, Instituto d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.
D001201:Ascites / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D005919:Glomerular Filtration Rate; D006530:Hepatorenal Syndrome / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000503:physiopathology; D007022:Hypotension / Q000209:etiology; D007668:Kidney / Q000098:blood supply; D008103:Liver Cirrhosis / Q000150:complications; D008236:Lypressin / Q000031:analogs & derivatives / Q000627:therapeutic use; D009951:Ornipressin / Q000627:therapeutic use; D019152:Paracentesis; D010536:Peritoneovenous Shunt; D010538:Peritonitis / Q000150:complications / Q000188:drug therapy; D010952:Plasma Substitutes / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000502:physiology; D013152:Splanchnic Circulation; D013564:Sympathetic Nervous System / Q000503:physiopathology; D013610:Tachycardia / Q000209:etiology; D000077585:Terlipressin; D014661:Vasoconstriction
D010952:Plasma Substitutes; D009951:Ornipressin; D008236:Lypressin; D000077585:Terlipressin